EUVIMED · CrossrefZeitschrift
Cell Metabolism
ISSN 1550-4131 · Elsevier BV
Neueste Artikel
A bedside-to-outside model of human nutrition research
Zonated cholesterol sensing by SIRT2 drives MASLD-HCC
Leveraging induced cell states for cancer therapy: The case for dynamic synthetic lethality
Adipose ILC2s depend on acetyl-CoA carboxylase 1 to maintain metabolic health
Microbial aldehyde-alcohol dehydrogenase degrades metformin to limit therapeutic response in type 2 diabetes
Fungus Rhizopus arrhizus promotes MASLD-associated hepatocellular carcinoma through generating kynurenic acid
Fueling the failing heart: SGLT2i directly activates the hidden PANK1
Histone lactylation scarring transmits metabolic and epigenetic memory across the gut-liver axis
On the interpretation of diet-specific metabolic effects following weight loss
Response to Magkos and Silva: Diet macronutrient content and metabolic function in metabolically unhealthy obesity
Lipid organization in health and disease
FcRn-dependent IgG accumulation in adipose tissue unmasks obesity pathophysiology
Distinguishing hepatic metabolic effects from overall cardiometabolic benefit after matched weight loss
An NAD+-responsive adipose signal coordinates inter-organ defense against muscle atrophy
Weight loss during intermittent fasting, not Mediterranean diet quality alone, is associated with lower inflammation: A randomized controlled trial
Propionate promotes MHC class I antigen presentation and anti-tumor immunity
Metformin-supportive nutrition: When gut microbes eat drugs
Lactate charging of tRNAs “brakes” the ribosome
Lipid droplet-induced T cell death sustains autoimmune tissue inflammation
Beyond bacteria: A fungal metabolite drives liver cancer from within
Beyond singular effectors: The futile creatine cycle from molecular mechanism to integrated adipocyte thermogenesis
Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response
Hepatic ALP links intestinal stem-cell fate to dysglycemia in fatty liver
From liver to L-cell: Clinical considerations for translating hepatic ALP signaling
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy
Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2+ CD8+ T effector cells
16-h fasting optimizes cancer immunotherapy in mice and humans
The interplay between the microbiome and immune cells in metabolic homeostasis and disease
GDF15 suppresses liver inflammation independently of weight loss through neuroendocrine glucocorticoid signaling
EUVIMED